Oppenheimer on WAVE Life Sciences (WVE): 'we would be buyers any weakness'
Tweet Send to a Friend
Oppenheimer analyst Cheng Li reiterated an Outperform rating and $32.00 price target on WAVE Life Sciences (NASDAQ: WVE)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
